C12Y 304/24029
Aureolysin
Official title: Aureolysin (3.4.24.29)
C12Y304/24029 (Aureolysin) appears on 21 US grants and 26 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 26
- Assignees
- 13
- Inventors
- 30
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 3 |
| 2011 | 0 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 0 |
| 2014 | 1 | 3 |
| 2015 | 1 | 4 |
| 2016 | 2 | 1 |
| 2017 | 3 | 3 |
| 2018 | 4 | 1 |
| 2019 | 3 | 3 |
| 2020 | 1 | 1 |
| 2021 | 2 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Peptide directed protein knockdown30 Sep 2025US 12,428,456 B2The University of British Columbia
- Mirac proteins8 Aug 2023US 11,718,844 B2BioAtla, Inc.
- Dual cistronic bacterial expression system21 Jun 2022US 11,365,418 B2Lupin Limited
- Peptide directed protein knockdown30 Nov 2021US 11,186,620 B2The University of British Columbia
- Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)30 Mar 2021US 10,961,304 B2B-Creative Sweden AB
- Method of Using r-SAK Prior to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction25 Dec 2025US 2025/0387459 A1Jiangsu Kanion Group Co., Ltd.
- Staphylococcal protein variants and truncates18 Sep 2025US 2025/0288657 A1Evaxion Biotech A/S
- Mirac proteins19 Oct 2023US 2023/0332135 A1BioAtla, Inc.
- Peptide directed protein knockdown24 Feb 2022US 2022/0056088 A1The University of British Columbia
- Split intein compositions23 Jan 2020US 2020/0024370 A1Ohio State Innovation Foundation
Most cited
By later US patents
- Mirac proteins26US 8,709,755 B2BioAtla, Inc. · 2014
- Mutants of streptokinase and their covalently modified forms14US 8,093,032 B2Council of Scientific and Industrial Research · 2012
- Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)7US 10,961,304 B2B-Creative Sweden AB · 2021
- Peptide directed protein knockdown3US 10,287,333 B2The University of British Columbia · 2019
- Mirac proteins3US 9,637,734 B2BioAtla, Inc. · 2017